Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
GlobeNewswire
· Advanced MYCHELANGELO™ I trial dose escalation to Cohort 5; Presentation of additional monotherapy data and planned expansion..